CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Hypoglycaemic clamp +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03014011
NCT03014011N/ACompleted

Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes

Bispebjerg Hospital·interventional·Posted Jan 9, 2017·Updated Jan 28, 2020

In Brief

A clinical study evaluating Hypoglycaemic clamp and Euglycaemic clamp for Diabetes Mellitus, Type II and 2 related conditions. Completed, enrolled 28 participants across 1 site.

Detailed Summary

Hypoglycaemia in subjects suffering from type 2 diabetes may have substantial consequences including a significant negative impact on quality of life. Further, repeated minor hypoglycaemias may result in significant productivity losses. Here, the investigators propose to provide quantitative results on cognition during an acute mild hypoglycaemic episode (target plasma glucose 3 mmol/L) in 28 subjects with type 2 diabetes. Data will be provided on executive function, attention and memory.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 9, 2017
Enrollment StartJun 13, 2017
Primary CompletionJul 23, 2018
Study CompletionJul 24, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.5 years ago

Interventions

Hypoglycaemic clampother

The clamp is performed by insulin and adjustable 20% glucose infusions, with the aim to lower and keep plasma blood glucose levels at 3 mmol/L for outcome measurements.

Euglycaemic clampother

The clamp is performed by insulin and adjustable 20% glucose infusions, with the aim to keep plasma blood glucose levels at 6 mmol/L for outcome measurements.